The Latest Cardiac and Vascular News
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, will showcase its clinical expertise and industry-leading innovation at the American Heart Association’s International Stroke Conference (ISC) in Phoenix, AZ, February 7-9. Through various research presentations, […]
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, is proud to announce major milestones in advancing its industry-leading deep clinical AI, including: Launch of its unique AI-based healthcare platform, Rapid Edge Cloud*, a hybrid (cloud and on-premise) technology infrastructure built to be faster, more secure, and flexible,
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, today announced it has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma. Together with Rapid ICH and Rapid Hyperdensity, the three modules comprise RapidAI’s unique and
SAN MATEO, Calif. & HOUSTON, Mo.–(BUSINESS WIRE)–RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, is pleased to announce Texas County Memorial Hospital’s (TCMH) implementation of RapidAI’s core stroke imaging and workflow products – including Rapid ICH, LVO, CTA and CTP – as part of its ongoing commitment to enhancing the quality of stroke care for patients in rural so
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced $75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data […]
The recognition comes on the heels of major achievements in the past year, including 5 FDA 510(k) clearances, the Frost & Sullivan Global Technology Innovation Leadership Award, and nearly 10 million patient scans SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in using AI to combat life-threatening vascular and neurovascular conditions […]
Part of RapidAI’s industry-leading stroke solution, Rapid NCCT Stroke supports faster treatment and transfer decisions while driving greater equity of care SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for Rapid NCCT […]
Integrated with the Rapid PE solution, Rapid RV/LV further accelerates time to triage and diagnose pulmonary embolism patients with right heart strain SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for Rapid RV/LV, […]
The fast, accurate, and proven RapidAI platform improves patient and staff experience and diagnostic accuracy, ensures high care team coordination, better health outcomes, and reduces costs. SAN ANTONIO, Sept. 12, 2022 /PRNewswire/ — Frost & Sullivan recently analyzed the artificial intelligence (AI) algorithms for the stroke market, and, based on its assessment results, recognizes RapidAI with […]
The new solution allows for quick identification of hyperdense volumes to improve hemorrhage management SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA clearance for Rapid Hyperdensity, the newest addition to the RapidAI platform. The tool empowers […]
